The FDA is alerting healthcare providers of a potential safety risk in some Hospira Carpuject pre-filled cartridges. The pre-filled cartridges containing morphine and hydromorphone may be overfilled by at least twice the expected amount, resulting in potential overdose.

Following initial complaints of overfilled Carpuject pre-filled cartridges, subsequent FDA inspection showed that this risk for overfilling has resulted in as many as 280 lots of 15 different Carpuject pre-filled cartridge products.

Rather than issuing a recall, the FDA is recommending that healthcare providers visually inspect and confirm that the Carpuject pre-filled cartridge contains the labeled fill volume before dispensing and again before administering to patients.

For more information visit